Diamyd Medical AB (DMYD B):企業の財務・戦略的SWOT分析

◆英語タイトル:Diamyd Medical AB (DMYD B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14986
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company’s diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other immunomodulatory agents. Diamyd’s GABA or gamma-aminobutyric acid is synthesized from the amino acid glutamate in cells by the enzyme GAD which helps in the regulation of metabolism and the immune system. The company develops treatment for autoimmune diabetes through pharmaceutical development and investments in medical and stem cell technology. Diamyd is headquartered in Stockholm, Sweden.

Diamyd Medical AB Key Recent Developments

Jan 23,2019: Diamyd Medical announces quarterly report I 18/19
Nov 01,2018: Internationally renowned diabetes expert proposed to join Diamyd Medical’s Board of Directors

This comprehensive SWOT profile of Diamyd Medical AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Diamyd Medical AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Diamyd Medical AB – Key Information
Diamyd Medical AB – Overview
Diamyd Medical AB – Key Employees
Diamyd Medical AB – Key Employee Biographies
Diamyd Medical AB – Key Operational Heads
Diamyd Medical AB – Major Products and Services
Diamyd Medical AB – History
Diamyd Medical AB – Company Statement
Diamyd Medical AB – Locations And Subsidiaries
Diamyd Medical AB – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Diamyd Medical AB – Business Description
Diamyd Medical AB – Corporate Strategy
Diamyd Medical AB – SWOT Analysis
SWOT Analysis – Overview
Diamyd Medical AB – Strengths
Diamyd Medical AB – Weaknesses
Diamyd Medical AB – Opportunities
Diamyd Medical AB – Threats
Diamyd Medical AB – Key Competitors

Section 3 – Company Financial Performance Charts

Diamyd Medical AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Diamyd Medical AB, Key Information
Diamyd Medical AB, Key Ratios
Diamyd Medical AB, Share Data
Diamyd Medical AB, Major Products and Services
Diamyd Medical AB, History
Diamyd Medical AB, Key Employees
Diamyd Medical AB, Key Employee Biographies
Diamyd Medical AB, Key Operational Heads
Diamyd Medical AB, Other Locations
Diamyd Medical AB, Subsidiaries
Diamyd Medical AB, Key Manufacturing facilities
Diamyd Medical AB, Key Competitors
Diamyd Medical AB, SWOT Analysis
Diamyd Medical AB, Ratios based on current share price
Diamyd Medical AB, Annual Ratios
Diamyd Medical AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Diamyd Medical AB, Performance Chart
Diamyd Medical AB, Ratio Charts

★海外企業調査レポート[Diamyd Medical AB (DMYD B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company prov …
  • William Hill PLC:企業の戦略・SWOT・財務分析
    William Hill PLC - Strategy, SWOT and Corporate Finance Report Summary William Hill PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • HDFC Bank Ltd:企業のM&A・事業提携・投資動向
    HDFC Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HDFC Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Fri-El Green Power SpA-エネルギー分野:企業M&A・提携分析
    Summary Fri-El Green Power SpA (Fri-El) is a renewable energy company that offers production of electric energy from renewable sources. The company develops, builds and manages power stations fuelled with biogas. Its wind energy is produced through wind turbine generators that convert wind to kineti …
  • Smiths Medical:企業の戦略的SWOT分析
    Smiths Medical - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • ZIOPHARM Oncology Inc (ZIOP)-製薬・医療分野:企業M&A・提携分析
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease …
  • Pierre & Vacances SA (VAC):企業の財務・戦略的SWOT分析
    Pierre & Vacances SA (VAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Japan Pulp and Paper Company Limited:企業の戦略・SWOT・財務分析
    Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • MRF Limited:企業の戦略・SWOT・財務情報
    MRF Limited - Strategy, SWOT and Corporate Finance Report Summary MRF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The British United Provident Association Limited :企業の戦略・SWOT・財務情報
    The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report Summary The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Tesaro Inc (TSRO)-医療機器分野:企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Puretech Health plc (PRTC):製薬・医療:M&Aディール及び事業提携情報
    Summary Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug ca …
  • Nestle Health Science SA-医療機器分野:企業M&A・提携分析
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • ManTech International Corporation:企業の戦略・SWOT・財務情報
    ManTech International Corporation - Strategy, SWOT and Corporate Finance Report Summary ManTech International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Zenotech Laboratories Ltd (532039):製薬・医療:M&Aディール及び事業提携情報
    Summary Zenotech Laboratories Ltd (Zenotech) manufactures and markets generic biopharmaceuticals products. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company’s Generic biopharmaceuticals is further sub-divided into generic biological an …
  • Hiscox Ltd:戦略・SWOT・企業財務分析
    Hiscox Ltd - Strategy, SWOT and Corporate Finance Report Summary Hiscox Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable) is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by which solar energy is converted to …
  • SANUWAVE Health Inc (SNWV):企業の製品パイプライン分析2018
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company offers products such as dermapace, which is used in the treatment of chronic and acute conditions o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆